Sandoz To Recall 17,000 MTX Injections, Some Allegedly With Glass Debris, In China
This article was originally published in PharmAsia News
Executive Summary
Sandoz Pharma will recall in China 17,000 methotrexate injections produced by its subsidiary EBEWE Pharma in compliance with the country's Provisions for Drug Recall, according to a report on China's official State FDA website